BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27151379)

  • 1. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
    García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
    An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of off-label drugs in neonatal intensive care].
    Sucasas Alonso A; Avila-Alvarez A; Combarro Eiriz M; Martínez Roca C; Yáñez Gómez P; Codias López A; Fernández Trisac JL; Pértega Díaz S
    An Pediatr (Engl Ed); 2019 Oct; 91(4):237-243. PubMed ID: 30772271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
    Dos Santos L; Heineck I
    Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.
    Arocas Casañ V; Cabezuelo Escribano B; Garrido-Corro B; De la Cruz Murie P; Blázquez Álvarez MJ; De la Rubia Nieto MªA
    Farm Hosp; 2017 May; 41(3):371-381. PubMed ID: 28478751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
    Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
    Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study.
    Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E
    Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug utilization pattern in children and off-label use of medicines in a pediatric intensive care unit.
    Blanco-Reina E; Medina-Claros AF; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Ruiz-Extremera Á
    Med Intensiva; 2016; 40(1):1-8. PubMed ID: 25583042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.
    Cuzzolin L; Agostino R
    Eur J Clin Pharmacol; 2016 Jan; 72(1):117-23. PubMed ID: 26490354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit].
    Ferreira Lde A; Ibiapina Cda C; Machado MG; Fagundes ED
    Rev Assoc Med Bras (1992); 2012; 58(1):82-7. PubMed ID: 22392321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
    Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug prescriptions study in the outpatient setting: assessment of off-label uses in children].
    Blanco-Reina E; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Bellido-Estévez I
    Aten Primaria; 2015; 47(6):344-50. PubMed ID: 25443768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan.
    Aamir M; Khan JA; Shakeel F; Asim SM
    Int J Clin Pharm; 2017 Aug; 39(4):860-866. PubMed ID: 28597174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran.
    Kouti L; Aletayeb M; Aletayeb SMH; Hardani AK; Eslami K
    BMC Pediatr; 2019 Jan; 19(1):3. PubMed ID: 30609923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study.
    Mazhar F; Akram S; Haider N; Hadi MA; Sultana J
    Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
    Kieran EA; O'Callaghan N; O'Donnell CP
    Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU).
    Jobanputra N; Save SU; Bavdekar SB
    Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
    Lee JL; Redzuan AM; Shah NM
    Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.